NYVAC immunization induces polyfunctional HIV-specific T-cell responses in chronically-infected, ART-treated HIV patients.
about
Evaluating the efficacy of therapeutic HIV vaccines through analytical treatment interruptionsThe evolution of poxvirus vaccinesNonreplicating vectors in HIV vaccines.The influence of delivery vectors on HIV vaccine efficacyImmune interventions in HIV infection.Deletion of C7L and K1L genes leads to significantly decreased virulence of recombinant vaccinia virus TianTanVirological and immunological characterization of novel NYVAC-based HIV/AIDS vaccine candidates expressing clade C trimeric soluble gp140(ZM96) and Gag(ZM96)-Pol-Nef(CN54) as virus-like particles.Therapeutic DNA vaccination of vertically HIV-infected children: report of the first pediatric randomised trial (PEDVAC)HIV-specific humoral responses benefit from stronger prime in phase Ib clinical trialInterleukin-1- and type I interferon-dependent enhanced immunogenicity of an NYVAC-HIV-1 Env-Gag-Pol-Nef vaccine vector with dual deletions of type I and type II interferon-binding proteins.Comparison of Immunogenicity in Rhesus Macaques of Transmitted-Founder, HIV-1 Group M Consensus, and Trivalent Mosaic Envelope Vaccines Formulated as a DNA Prime, NYVAC, and Envelope Protein BoostHead-to-Head Comparison of Poxvirus NYVAC and ALVAC Vectors Expressing Identical HIV-1 Clade C Immunogens in Prime-Boost Combination with Env Protein in Nonhuman PrimatesThe Effect of Therapeutic HIV Vaccination With ALVAC-HIV With or Without Remune on the Size of the Viral Reservoir (A CTN 173 Substudy).The EPIICAL project: an emerging global collaboration to investigate immunotherapeutic strategies in HIV-infected children.Toward a cure for HIV--Seeking effective therapeutic vaccine strategies.A heterologous prime-boosting strategy with replicating Vaccinia virus vectors and plant-produced HIV-1 Gag/dgp41 virus-like particles.Distinct Roles of Vaccinia Virus NF-κB Inhibitor Proteins A52, B15, and K7 in the Immune Response.HIV/AIDS Vaccine Candidates Based on Replication-Competent Recombinant Poxvirus NYVAC-C-KC Expressing Trimeric gp140 and Gag-Derived Virus-Like Particles or Lacking the Viral Molecule B19 That Inhibits Type I Interferon Activate Relevant HIV-1-SpeciA Phase I Randomized Therapeutic MVA-B Vaccination Improves the Magnitude and Quality of the T Cell Immune Responses in HIV-1-Infected Subjects on HAART.Immunogenicity of NYVAC prime-protein boost HIV-1 envelope vaccination and SHIV challenge of nonhuman primates.
P2860
Q26777442-15008540-56BB-44FE-AA64-C6EA94CC8EFAQ26995905-091E67BE-B44D-4DE3-A0B2-B686747D82D0Q33693891-503D84BB-3CF6-4CF5-B361-B2AD32148C12Q34077543-B9D74D92-B6A9-4347-9CD1-FBB50F15B29BQ34351326-F5A688BF-059C-403D-91B4-57950918891AQ34809121-C9826D89-2690-494B-8129-88F178C19F2BQ34991112-37959C0C-E94B-4023-BBF4-217F746B9FC6Q35060232-BDF70FD8-9427-4E0A-B1A0-EB784A9B1D47Q35140001-75881704-24EA-4DD9-AF1E-514EF08F63CCQ35488175-3343B450-6718-4334-87EF-33F5D4CA1668Q35760486-22040A80-6CE8-45FA-AF6B-2F986D4CCA44Q35914311-5C670DB8-237E-4D4A-94DF-BB5B24739DE8Q36080407-28C07F40-2CFC-4751-8B5C-610AD4F4414FQ38505356-DD07C8E4-4938-48AC-AC0D-E4E58A05876AQ38626469-74FEC08D-5AFE-4D3B-8FA3-48FE5E4F4B7CQ40220988-EAB510B4-41D7-46AA-8EA5-FDD56BCF623EQ40235609-AF008295-4B82-499A-AAAF-C78BEBB98198Q40339467-E737065C-25A2-4278-AB8D-3C5E85018986Q40919787-226DE5F3-7429-462F-B3E2-793B9C7E80A6Q50043326-971769E6-1439-46AD-9435-912D85459F48
P2860
NYVAC immunization induces polyfunctional HIV-specific T-cell responses in chronically-infected, ART-treated HIV patients.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
NYVAC immunization induces pol ...... ted, ART-treated HIV patients.
@en
NYVAC immunization induces pol ...... ted, ART-treated HIV patients.
@nl
type
label
NYVAC immunization induces pol ...... ted, ART-treated HIV patients.
@en
NYVAC immunization induces pol ...... ted, ART-treated HIV patients.
@nl
prefLabel
NYVAC immunization induces pol ...... ted, ART-treated HIV patients.
@en
NYVAC immunization induces pol ...... ted, ART-treated HIV patients.
@nl
P2093
P2860
P50
P356
P1476
NYVAC immunization induces pol ...... ted, ART-treated HIV patients.
@en
P2093
Brigitte Autran
Christiane Moog
Daniel Garin
Erika Castro
Felicitas Bellutti Enders
Gonzalo Tapia
Joep Lange
Pierre-Alexandre Bart
Selena Vigano
Séverine Burnet
P2860
P304
P356
10.1002/EJI.201242696
P407
P577
2012-10-01T00:00:00Z